Form 4 for CC Chemours Co
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001209191-23-016099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-01 | CC | Newman Mark | Pres, CEO, Dir | F - Tax | $34.84 | -5,248 | 216.1K | -2% | -$182.8K |
| D | 2023-03-03 | 2023-03-01 | CC | Newman Mark | Pres, CEO, Dir | A - Grant | $0.00 | +43.1K | 259.2K | +20% | $0 |
| DM | 2023-03-03 | 2023-03-01 | CC | Newman Mark | Pres, CEO, Dir | A - Grant | $0.00 | +193.9K | 96.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | F | D | 5,248 | $34.84 | 216,118.90 | D | — | — | (F1) Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. (F2) Includes directly owned shares, restricted stock units and dividend equivalent units. |
| 2 | Common | Common Stock | 2023-03-01 | A | A | 43,053 | $0.00 | 259,171.90 | D | — | — | (F3) Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. (F2) Includes directly owned shares, restricted stock units and dividend equivalent units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-03-01 | A | A | 97,656 | $0.00 | 97,656 | D | $34.84 · — to 2033-03-01 | 97,656 Common Stock | (F4) These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. |
| 4 | Derivative | Performance Stock Option (Right to Buy) | 2023-03-01 | A | A | 96,277 | $0.00 | 96,277 | D | $38.32 · — to 2033-03-01 | 96,277 Common Stock | (F5) Represents a 10 percent premium above the closing price of the Company common stock on the date of grant (F4) These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. |